Franklin Resources
PMVP icon

Franklin Resources’s PMV Pharmaceuticals PMVP Stock Holding History

Franklin Resources’s Portfolio PMVP Stock Details PMVP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-219,607
Closed -$7.5M – 2489
2021
Q2 		$7.5M Buy
219,607
+19,600
+10% +$655K ﹤0.01% 1060
2021
Q1 		$6.58M Hold
200,007
– – ﹤0.01% 1060
2020
Q4 		$12.3M Buy
200,007
+7
+0% +$275 0.01% 918
2020
Q3 		$7.1M Buy
+200,000
New +$7.36M ﹤0.01% 974

Other funds holding PMVP

O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
IVM
InterWest Venture Management San Francisco, California $20.6M AUM 48.5% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Franklin Resources's PMVP Position: Q3 2021 in Review

Franklin Resources sold out of PMV Pharmaceuticals (PMVP) in Q3 2021, closing a stake of 219,607 shares — an estimated $7.5M sold.

Franklin Resources first reported a position in PMVP in Q3 2020 and held it in 4 quarters. The position peaked at $12.3M in Q4 2020. 92 funds tracked by Wall St. Rank hold PMVP as of Q3 2021.

  • Franklin Resources reported no remaining PMV Pharmaceuticals position as of Q3 2021 after selling out during the quarter.
  • Franklin Resources sold 219,607 PMV Pharmaceuticals shares in Q3 2021, an estimated $7.5M.
  • Franklin Resources first reported a position in PMV Pharmaceuticals in Q3 2020 and held it in 4 quarters.
  • Franklin Resources's PMV Pharmaceuticals position peaked at $12.3M in Q4 2020.
  • 92 funds tracked by Wall St. Rank held PMV Pharmaceuticals as of Q3 2021.

Based on Franklin Resources's 13F filing for Q3 2021, filed 12 Nov 2021.